Evaluation of Patients Hospitalized Due to Bleeding Complications Associated with Warfarin Treatment

Authors : Fatih Eren, Engin Sennaroglu
Pages : 187-192
Doi:10.32708/uutfd.1668151
View : 72 | Download : 79
Publication Date : 2025-08-28
Article Type : Research Paper
Abstract :The most significant complication of warfarin therapy is bleeding. The disadvantages of warfarin include its narrow therapeutic range and drug-drug interactions. This study aimed to determine the severity of bleeding events associated with warfarin treatment, mortality, and factors that may influence these outcomes. A total of 119 patients hospitalized due to bleeding complications associated with warfarin use between January 2007 and December 2010 were included in the study. Demographic and clinical data—including age, gender, comorbidities, International Normalized Ratio (INR), and mortality—were analyzed. Bleeding severity was classified according to the Fihn criteria as minor bleeding and major bleeding (severe, life-threatening and fatal bleeding). Fifty-six patients (51.4%) were female,53 (48.6%) were male, and 53.2% of the patients were aged 65 years and older. Hypertension (50.5%) and diabetes mellitus (22.0%) were the most common comorbid conditions. The primary indications for warfarin use were atrial fibrillation (35.8%), followed by cardiovascular diseases (32.1%), history of stroke (26.6%), and prosthetic heart valve (22.0%). The most common presenting symptoms were ecchymosis and upper gastrointestinal bleeding. Major bleeding was significantly more common in males (p=0.046). Ninety-eight percent (n=107) of patients experiencing bleeding had supratherapeutic INR values. Mortality was significantly higher in patients aged 65 years and older (p=0.029). There was no significant difference between genders in terms of overall bleeding event frequency and mortality. In conclusion, advanced age and labile INR are significant factors in warfarin-related bleeding events. Mortality due to warfarin-related bleeding is significantly higher in older patients.
Keywords : oral antikoagülan tedavi, warfarin, kanama, hemoraji

ORIGINAL ARTICLE URL